Blandine Manot-Saillet

Blandine Manot-Saillet

Auto-generated profile, based on publicly available information

Blandine Manot-Saillet

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, “Team: Interactions between neurons and oligodendroglia in myelination and myelin repair

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SMSabah Mozafari
Sabah Mozafari
LSLaura Starost
Laura Starost
BMBlandine Manot-Saillet
Blandine Manot-Saillet
BDBeatriz Garcia Diaz
Beatriz Garcia Diaz
YXYu Kang T. Xu
Yu Kang T. Xu
AEAnne Baron-Van Evercooren
Anne Baron-Van Evercooren
MS-derived oligodendrocytes conserve their ability to fully interact with axons and glial cells in vivo.

18 November 2025 in bioRxiv
Verified
Preprint
Open access
DMDorien A. Maas
Dorien A. Maas
RBRoxane Bancel-Vega
Roxane Bancel-Vega
LBLucas R. Baudouin
Lucas R. Baudouin
PBPhilippe Bun
Philippe Bun
BMBlandine Manot-Saillet
Blandine Manot-Saillet
MAMaria Cecilia Angulo
Maria Cecilia Angulo
Oligodendrocyte (OL) lineage cells drive central nervous system remyelination, yet the intrinsic mechanisms that define their regenerative potential remain unclear. We identify spontaneous, cell-autonomous intracellular Ca 2+ signaling as a critical mechanism regulating OL regeneration following demyelination. Longitudinal in vivo imaging and ex vivo recordings reveal that Ca 2+ signaling arises intrinsically within OL lineage cells after demyelination, and occurs independently from neuronal or behavioral activity. Mechanistically, mitochondrial Ca 2+ flux sustains intracellular Ca 2+ signals in oligodendroglia, and its in vivo disruption impairs oligodendrocyte precursor cell (OPC) proliferation, differentiation, and repopulation at the lesion site. Conversely, enhancing oligodendroglial Ca 2+ signaling in vivo using chemogenetics stimulates lineage expansion and differentiation. In primary human OPC cultures, modulation of mitochondrial Ca 2+ flux similarly reduces proliferation, indicating a conserved role for this pathway across species. These findings identify mitochondrial Ca 2+ flux as a central driver of the oligodendroglial regeneration and a potential therapeutic target in demyelinating diseases.

18 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDorien A. Maas
Dorien A. Maas
BMBlandine Manot-Saillet
Blandine Manot-Saillet
PBPhilippe Bun
Philippe Bun
CHChloé Habermacher
Chloé Habermacher
CPCorinne Poilbout
Corinne Poilbout
MAMaria Cecilia Angulo
Maria Cecilia Angulo
Intracellular Ca 2+ signals of oligodendroglia, the myelin-forming cells of the central nervous system, regulate vital cellular processes including myelination. However, studies on oligodendroglia Ca 2+ signal dynamics are still scarce, especially during myelin repair, and there are no software solutions to properly analyze the unique Ca 2+ signal characteristics in these cells. Here, we provide a comprehensive experimental and analytical workflow to acquire and analyze Ca 2+ imaging data of oligodendroglia at the population and single-cell levels in preclinical mouse models of myelin repair. We report diverse ex vivo and in vivo experimental protocols to obtain reproducible Ca 2+ imaging data from oligodendroglia in demyelinated lesions. Importantly, we provide an analytical pipeline containing two free, open source and cross-platform software programs, Occam and post-prOccam, that enable the fully automated analysis of one- and two-photon Ca 2+ imaging datasets from oligodendroglia obtained by either ex vivo or in vivo Ca 2+ imaging techniques. This versatile and accessible experimental and analytical framework, which revealed significant but uncorrelated spontaneous Ca 2+ activity in oligodendroglia inside demyelinated lesions, should facilitate the elucidation of Ca 2+ -mediated mechanisms underlying remyelination and therefore help to accelerate the development of therapeutic strategies for the many myelin-related disorders, such as multiple sclerosis.